Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $2.60 in the prior trading day, Alto Neuroscience Inc (NYSE: ANRO) closed at $2.63, up 1.15%. In other words, the price has increased by $1.15 from its previous closing price. On the day, 1.25 million shares were traded.
Ratios:
Our goal is to gain a better understanding of ANRO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 22.53 and its Current Ratio is at 22.53. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wedbush on October 23, 2024, Downgraded its rating to Neutral and sets its target price to $4 from $29 previously.
On September 03, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $29.Wedbush initiated its Outperform rating on September 03, 2024, with a $29 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 09 ’24 when Savitz Adam bought 12,069 shares for $12.60 per share. The transaction valued at 152,085 led to the insider holds 36,920 shares of the business.
Savitz Adam bought 2,931 shares of ANRO for $38,748 on Jul 10 ’24. The CHIEF MEDICAL OFFICER now owns 39,851 shares after completing the transaction at $13.22 per share.
Stock Price History:
Over the past 52 weeks, ANRO has reached a high of $17.55, while it has fallen to a 52-week low of $1.60. The 50-Day Moving Average of the stock is 10.71%, while the 200-Day Moving Average is calculated to be -52.68%.
Shares Statistics:
A total of 27.07M shares are outstanding, with a floating share count of 21.49M. Insiders hold about 20.61% of the company’s shares, while institutions hold 76.53% stake in the company.
